Prescription Drug Marketing Act Explained

Shorttitle:Prescription Drug Marketing Act of 1987
Longtitle:An Act to amend the Federal Food, Drug, and Cosmetic Act to ban the reimportation of drugs produced in the United States, to place restrictions on the distribution of drug samples, to ban certain resales of drugs by hospitals and other health care facilities, and for other purposes.
Enacted By:100th
Effective Date:April 22, 1988
Public Law Url:http://www.gpo.gov/fdsys/pkg/STATUTE-102/pdf/STATUTE-102-Pg95.pdf
Cite Public Law:100-293
Acts Amended:Federal Food, Drug and Cosmetic Act
Title Amended:21 U.S.C.: Food and Drugs
Sections Amended: §§ 331, 353, 381
Leghisturl:http://thomas.loc.gov/cgi-bin/bdquery/z?d100:HR01207:@@@X
Introducedin:House
Introducedby:John Dingell (DMI)
Introduceddate:February 24, 1987
Committees:House Committee on Energy and Commerce
Passedbody1:House
Passeddate1:May 4, 1987
Passedvote1:passed voice vote
Passedbody2:Senate
Passeddate2:March 31, 1988
Passedvote2:passed voice vote
Signedpresident:Ronald Reagan
Signeddate:April 22, 1988
Amendments:Prescription Drug Amendments of 1992 P.L. 102-353, 106 Stat. 941

The Prescription Drug Marketing Act (PDMA) of 1987 (P.L. 100-293, 102 Stat. 95) is a law of the United States federal government. It establishes legal safeguards for prescription drug distribution to ensure safe and effective pharmaceuticals and is designed to discourage the sale of counterfeit, adulterated, misbranded, sub potent, and expired prescription drugs. It was passed in response to the development of a wholesale sub-market (known as the "diversion market") for prescription drugs.

The PDMA was modified by the Prescription Drug Amendments of 1992 (P.L. 102-353, 106 Stat. 941) on August 26, 1992.

The U.S. Food and Drug Administration (FDA) issued regulations implementing the PDMA in 1990 (21 C.F.R. Part 205) and 1999 (21 C.F.R. Part 203).

See also

External links